Where is metabolic medicine heading – and what do you need to know?

What happens when pipeline promise becomes market reality? During this PBSS webinar, Scott Morano and Roberto Cortese expertly guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next.

Topics covered include:

• Recent milestones: Key developments in cardiovascular and metabolic disease, including GLP-1s and MASH approvals
• Pipeline deep-dive: Phase 2 and Phase 3 molecules – trial designs, mechanisms of action, efficacy/safety profiles, and distinctive features
• Competitive landscape: Comparative analysis of assets across therapy areas
• Market dynamics: Latest deal and acquisition activity shaping the field
• What's next: Current, next-generation, and future drugs on the horizon

Watch the Recording below.